| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |